
Thursday, May 13, 2021 1:00:10 PM
Recent OPK News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 09:21:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 09:19:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 09:13:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 09:12:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 09:10:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2025 08:09:15 PM
- OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 • GlobeNewswire Inc. • 04/17/2025 12:00:00 PM
- NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program • PR Newswire (US) • 04/11/2025 08:05:00 PM
- OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program • GlobeNewswire Inc. • 04/04/2025 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/03/2025 09:21:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2025 09:13:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2025 11:29:25 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/21/2025 09:20:22 PM
- OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders • GlobeNewswire Inc. • 03/17/2025 12:00:00 PM
- OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders • GlobeNewswire Inc. • 03/17/2025 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/14/2025 08:22:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/14/2025 08:19:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2025 11:10:00 AM
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses • PR Newswire (US) • 03/11/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2025 09:12:11 PM
- OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 02/27/2025 09:10:15 PM
- OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025 • GlobeNewswire Inc. • 02/13/2025 09:05:00 PM
7.2 MW Glor Rd Solar Project in Development by SolarBank in New York • GY2 • Apr 29, 2025 9:06 AM
Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology • AVAI • Apr 29, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Alco Prevention Canada for BreathLogix Autonomous Alcohol Breathalyzer • BLO • Apr 28, 2025 8:49 AM
Veri Medtech (VRHI) Retains PCAOB Auditor • VRHI • Apr 28, 2025 8:30 AM
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement • COEP • Apr 25, 2025 8:33 AM
UAV Corp. Successfully Completes Inflation Test of DART SA-70 Airship, Paving Way for Flight Readiness • UMAV • Apr 24, 2025 8:30 AM